Alex Zhavoronkov
InvestorCo-founder and Head of the Advisory Board at LongeVC
Find your path to Alex
41 people in our graph share verified history with Alex — schools, employers, funds. One of them is your warm intro.
About
Alex Zhavoronkov is the CEO of Insilico Medicine, a Baltimore-based company applying artificial intelligence and blockchain to drug discovery, biomarker development, and aging research. He co-founded LongeVC and heads its Advisory Board, and previously held senior roles at ATI Technologies, NeuroG Neuroinformatics, the Biogerontology Research Foundation, and YLabs.AI. He holds two Bachelor's degrees from Queen's University, a Master's in Biotechnology from Johns Hopkins University, and a PhD in Physics and Mathematics from Moscow State University.
Contact· self-published, not guessed
Invests in
AI & Machine LearningBiotechLongevity
Colleagues at LongeVC
Frequently asked questions
- Who is Alex Zhavoronkov?
- Alex Zhavoronkov is the CEO of Insilico Medicine, a Baltimore-based company applying artificial intelligence and blockchain to drug discovery, biomarker development, and aging research. He co-founded LongeVC and heads its Advisory Board, and previously held senior roles at ATI Technologies, NeuroG Neuroinformatics, the Biogerontology Research Foundation, and YLabs.AI. He holds two Bachelor's degrees from Queen's University, a Master's in Biotechnology from Johns Hopkins University, and a PhD in Physics and Mathematics from Moscow State University.
- Where does Alex Zhavoronkov work?
- Alex Zhavoronkov is Co-founder and Head of the Advisory Board at LongeVC.
- What does Alex Zhavoronkov invest in?
- Alex Zhavoronkov invests in AI & Machine Learning, Biotech, Longevity.